Suppr超能文献

相似文献

2
TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapy.
Br J Cancer. 2017 Aug 8;117(4):503-512. doi: 10.1038/bjc.2017.197. Epub 2017 Jul 4.
3
The Evolution of Tumour Composition During Fractionated Radiotherapy: Implications for Outcome.
Bull Math Biol. 2018 May;80(5):1207-1235. doi: 10.1007/s11538-018-0391-9. Epub 2018 Feb 27.
5
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence.
Nat Rev Cancer. 2015 Jul;15(7):409-25. doi: 10.1038/nrc3958.
6
Inhibition of Fatty Acid Synthase Sensitizes Prostate Cancer Cells to Radiotherapy.
Radiat Res. 2015 Nov;184(5):482-93. doi: 10.1667/RR14173.1. Epub 2015 Oct 20.
7
3D tumour spheroids for the prediction of the effects of radiation and hyperthermia treatments.
Sci Rep. 2020 Feb 3;10(1):1653. doi: 10.1038/s41598-020-58569-4.
8
miR-191 promotes radiation resistance of prostate cancer through interaction with RXRA.
Cancer Lett. 2020 Mar 31;473:107-117. doi: 10.1016/j.canlet.2019.12.025. Epub 2019 Dec 23.
10
MicroRNA-145 Modulates Tumor Sensitivity to Radiation in Prostate Cancer.
Radiat Res. 2015 Dec;184(6):630-8. doi: 10.1667/RR14185.1. Epub 2015 Dec 3.

引用本文的文献

2
Phytochemical synergies in BK002: advanced molecular docking insights for targeted prostate cancer therapy.
Front Pharmacol. 2025 Feb 17;16:1504618. doi: 10.3389/fphar.2025.1504618. eCollection 2025.
4
5
Simulating Interclonal Interactions in Diffuse Large B-Cell Lymphoma.
Bioengineering (Basel). 2023 Nov 27;10(12):1360. doi: 10.3390/bioengineering10121360.
6
Efficient Radial-Shell Model for 3D Tumor Spheroid Dynamics with Radiotherapy.
Cancers (Basel). 2023 Nov 29;15(23):5645. doi: 10.3390/cancers15235645.
7
The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth and Potentiates Radiotherapy.
Cancer Res Commun. 2022 Sep 28;2(9):1075-1088. doi: 10.1158/2767-9764.CRC-22-0053. eCollection 2022 Sep.
8
Mathematical modeling of radiotherapy and its impact on tumor interactions with the immune system.
Neoplasia. 2022 Jun;28:100796. doi: 10.1016/j.neo.2022.100796. Epub 2022 Apr 19.
9
Designing and interpreting 4D tumour spheroid experiments.
Commun Biol. 2022 Jan 24;5(1):91. doi: 10.1038/s42003-022-03018-3.

本文引用的文献

1
Modeling heterogeneous tumor growth dynamics and cell-cell interactions at single-cell and cell-population resolution.
Curr Opin Syst Biol. 2019 Oct;17:24-34. doi: 10.1016/j.coisb.2019.09.005. Epub 2019 Sep 16.
2
Cooperative adaptation to therapy (CAT) confers resistance in heterogeneous non-small cell lung cancer.
PLoS Comput Biol. 2019 Aug 26;15(8):e1007278. doi: 10.1371/journal.pcbi.1007278. eCollection 2019 Aug.
3
Fibroblasts and alectinib switch the evolutionary games played by non-small cell lung cancer.
Nat Ecol Evol. 2019 Mar;3(3):450-456. doi: 10.1038/s41559-018-0768-z. Epub 2019 Feb 18.
4
Ecology and evolution of facilitation among symbionts.
Nat Commun. 2018 Nov 19;9(1):4869. doi: 10.1038/s41467-018-06779-w.
5
Phenotype-independent DNA methylation changes in prostate cancer.
Br J Cancer. 2018 Oct;119(9):1133-1143. doi: 10.1038/s41416-018-0236-1. Epub 2018 Oct 15.
6
Optimizing Cancer Treatment Using Game Theory: A Review.
JAMA Oncol. 2019 Jan 1;5(1):96-103. doi: 10.1001/jamaoncol.2018.3395.
7
Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity.
Nat Commun. 2018 Jun 20;9(1):2419. doi: 10.1038/s41467-018-04724-5.
8
Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies.
Cancer Res. 2018 Apr 15;78(8):2127-2139. doi: 10.1158/0008-5472.CAN-17-2649. Epub 2018 Jan 30.
9
Spatial competition constrains resistance to targeted cancer therapy.
Nat Commun. 2017 Dec 8;8(1):1995. doi: 10.1038/s41467-017-01516-1.
10
Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer.
Nat Commun. 2017 Nov 28;8(1):1816. doi: 10.1038/s41467-017-01968-5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验